Table 2 |
|||||
|
Correlation of immunohistochemical and clinical data |
|||||
|
Duration (months) |
Skin score |
Capillary pattern |
Collagen synthesis |
Myofibroblasts |
|
|
|
|||||
|
Patient 1 |
4 |
19 |
L |
- |
+++ |
|
Patient 2 |
6 |
24 |
A |
+++ |
+ |
|
Patient 3 |
7 |
41 |
A |
- |
+++ |
|
Patient 4 |
9 |
38 |
N/D |
- |
+++ |
|
Patient 5 |
9 |
39 |
N/D |
+++ |
+++ |
|
Patient 6 |
10 |
34 |
A |
- |
+++ |
|
Patient 7 |
11 |
40 |
L |
+++ |
- |
|
Patient 8 |
14 |
36 |
L |
- |
- |
|
Patient 9 |
18 |
32 |
L |
- |
- |
|
Patient 10 |
18 |
32 |
L |
+++ |
+++ |
|
|
|||||
|
Immunohistochemistry is quantified as; -, absent, +, weak, +++, strong. Patterns of capillary damage are graded as A, active, L, late or N/D, not determined. |
|||||
|
Rajkumar et al. Arthritis Research & Therapy 2005 7:R1113 doi:10.1186/ar1790 |
|||||